AOnychomycosis
First line
Onychomycosis
First line
Amorolfine 5% nail lacquer is first-line for mild onychomycosis: distal and lateral involvement of less than 50% of the nail plate, no matrix involvement and few affected nails. AEDV and CKS Fungal nail infection 2023 recommend application 1–2 times per week for 6–12 months. Cochrane CD012093 (Iorizzo 2020): complete cure rates 17–54% depending on disease severity. Matrix involvement, more than 50% plate disease or multiple affected nails do not respond to lacquer monotherapy – systemic terbinafine or itraconazole is needed, sometimes combined with lacquer. If amorolfine was prescribed as monotherapy for severe nail disease, consider seeking a second opinion.
Sources
ICD-10: B35.1 · ICD-11: EE12.1